Literature DB >> 9918936

Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.

R J Lenhoff1, C A Luscombe, J Summers.   

Abstract

A variant avian hepadnavirus that has been shown to destroy hepatocytes in vitro was found to be cytopathic in vivo. A single amino acid change of glycine to glutamic acid at position 133 (G133E) in the preS protein of duck hepatitis B virus (DHBV) caused an increase in the intranuclear pool of viral covalently closed circular DNA (cccDNA), resulting in a transient elevation of viral replication and eventual hepatocyte destruction. In vivo viral infection with the G133E virus was compared with infection with wild-type virus over a 72-day period. Birds were inoculated with virus at day 2 post-hatch to ensure a high percentage of infected hepatocytes and potential persistence of virus. Birds infected with the G133E virus had increased periportal cellular proliferation and numerous lysed apoptotic hepatocytes following 100% infection of hepatocytes. The liver damage within G133E virus-infected birds subsided over time, resulting in mild chronic hepatitis that was similar to that observed within wild-type virus-infected birds. The subsidence of liver damage in G133E virus-infected birds coincided with a reduction of viral cccDNA to wild-type virus levels in the liver. Our study indicates that maintenance of wild-type levels of viral cccDNA promotes persistence of virus infection by establishing a noncytopathic infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918936     DOI: 10.1002/hep.510290236

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Frequency of spontaneous mutations in an avian hepadnavirus infection.

Authors:  I Pult; N Abbott; Y Y Zhang; J Summers
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.

Authors:  W Yang; J Summers
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 4.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

5.  Age-related differences in amplification of covalently closed circular DNA at early times after duck hepatitis B virus infection of ducks.

Authors:  Yong-Yuan Zhang; Daniel P Theele; Jesse Summers
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 6.  Pathogenesis of hepatitis B virus infection.

Authors:  Thomas F Baumert; Robert Thimme; Fritz von Weizsäcker
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

7.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

8.  Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus.

Authors:  Philip Meuleman; Louis Libbrecht; Stefan Wieland; Rita De Vos; Nagy Habib; Anna Kramvis; Tania Roskams; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

10.  Rapid production of neutralizing antibody leads to transient hepadnavirus infection.

Authors:  Yong-Yuan Zhang; Jesse Summers
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.